EcoR1 Capital as of June 30, 2019
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 38 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Kura Oncology (KURA) | 10.5 | $104M | 5.3M | 19.69 | |
Xencor (XNCR) | 9.7 | $96M | 2.3M | 40.93 | |
Argenx Se (ARGX) | 8.3 | $82M | 581k | 141.58 | |
Fibrogen (FGEN) | 8.2 | $81M | 1.8M | 45.18 | |
Crispr Therapeutics (CRSP) | 7.7 | $76M | 1.6M | 47.10 | |
Spark Therapeutics | 6.3 | $63M | 614k | 102.38 | |
Mirati Therapeutics | 6.2 | $62M | 598k | 103.00 | |
Dicerna Pharmaceuticals | 5.3 | $52M | 3.3M | 15.75 | |
Ironwood Pharmaceuticals (IRWD) | 5.2 | $51M | 4.7M | 10.94 | |
Morphic Hldg (MORF) | 4.5 | $45M | 2.3M | 19.82 | |
Ultragenyx Pharmaceutical (RARE) | 3.2 | $32M | 498k | 63.50 | |
Prevail Therapeutics Ord | 3.2 | $32M | 2.4M | 13.20 | |
Atreca Inc Cl A (BCEL) | 2.8 | $28M | 1.5M | 18.84 | |
Chiasma | 2.3 | $23M | 3.0M | 7.47 | |
Harpoon Therapeutics | 1.8 | $18M | 1.3M | 13.00 | |
Gossamer Bio (GOSS) | 1.7 | $17M | 772k | 22.18 | |
ArQule | 1.4 | $14M | 1.3M | 11.01 | |
Eiger Biopharmaceuticals | 1.2 | $12M | 1.1M | 10.60 | |
Arcus Biosciences Incorporated (RCUS) | 1.2 | $12M | 1.5M | 7.92 | |
Unity Biotechnology | 1.0 | $9.9M | 1.0M | 9.50 | |
Cyclerion Therapeutics | 0.9 | $8.9M | 776k | 11.45 | |
Prothena (PRTA) | 0.8 | $7.6M | 723k | 10.57 | |
Rubius Therapeutics | 0.7 | $7.3M | 463k | 15.73 | |
Assembly Biosciences | 0.7 | $6.7M | 498k | 13.49 | |
Surface Oncology | 0.7 | $6.5M | 2.3M | 2.82 | |
Mersana Therapeutics (MRSN) | 0.6 | $5.6M | 1.4M | 4.05 | |
Curis | 0.6 | $5.5M | 3.0M | 1.86 | |
Aquinox Pharmaceuticals | 0.5 | $5.3M | 2.3M | 2.36 | |
Rhythm Pharmaceuticals (RYTM) | 0.5 | $4.9M | 223k | 22.00 | |
Solid Biosciences | 0.5 | $4.8M | 827k | 5.75 | |
Ngm Biopharmaceuticals | 0.5 | $4.6M | 317k | 14.64 | |
Kezar Life Sciences (KZR) | 0.5 | $4.5M | 583k | 7.71 | |
Aduro Biotech | 0.3 | $2.7M | 1.8M | 1.54 | |
Vericel (VCEL) | 0.2 | $2.5M | 131k | 18.89 | |
Syros Pharmaceuticals | 0.2 | $2.3M | 249k | 9.26 | |
Regulus Therapeutics | 0.1 | $1.4M | 1.1M | 1.25 | |
Gamida Cell | 0.0 | $265k | 52k | 5.08 | |
Tcr2 Therapeutics Inc cs | 0.0 | $231k | 16k | 14.34 |